Brief: Dawnrays Pharmaceutical HY Profit Attributable Rises 28.5%
27/08/2021 06:34
Aug 27 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
2348.HK :
* DECLARED INTERIM DIVIDEND OF HK$0.015 PER SHARE
* HY PROFIT ATTRIBUTABLE RMB166.6 MILLION, UP 28.5%
* HY REVENUE RMB 608.6 MILLION VERSUS RMB 489 MILLION
Source text for Eikon: ID:nHKS50s3Zj
Further company coverage: 2348.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO